miR-9对GSK-3β的靶向抑制作用调节膀胱癌细胞的增殖和凋亡。
Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
作者信息
Dong Z-C, Zhang D, Wang S-B, Lin Z-Q
机构信息
Department of Urology, Gansu Nephro-Urological Clinical Center, Key Laboratory of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
出版信息
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10301. doi: 10.26355/eurrev_202010_23351.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells, by Z.-C. Dong, D. Zhang, S.-B. Wang, Z.-Q. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22 (10): 3018-3026-DOI: 10.26355/eurrev_201805_15059-PMID: 29863246" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/15059.
由于本文涉嫌研究不当行为，且通讯作者未回应我们关于证明数据和图表原创性的要求，因此Z.-C. Dong、D. Zhang、S.-B. Wang、Z.-Q. Lin发表于《欧洲医学与药理学评论》2018年；22(10): 3018 - 3026 - DOI: 10.26355/eurrev_201805_15059 - PMID: 29863246的“miR - 9对GSK - 3β的靶向抑制作用调节膀胱癌细胞的增殖和凋亡”一文已被撤回。出版方对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/15059
Zotero 插件